Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3655064
Max Phase: Preclinical
Molecular Formula: C34H44FN3O2S
Molecular Weight: 577.81
Molecule Type: Small molecule
Associated Items:
ID: ALA3655064
Max Phase: Preclinical
Molecular Formula: C34H44FN3O2S
Molecular Weight: 577.81
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(c1ccc(C(C)(C)C)nc1)N1CCc2cc(S(=O)(=O)Nc3ccc(CCCC4CCCC4)cc3F)ccc2C1
Standard InChI: InChI=1S/C34H44FN3O2S/c1-24(28-14-17-33(36-22-28)34(2,3)4)38-19-18-27-21-30(15-13-29(27)23-38)41(39,40)37-32-16-12-26(20-31(32)35)11-7-10-25-8-5-6-9-25/h12-17,20-22,24-25,37H,5-11,18-19,23H2,1-4H3
Standard InChI Key: DUVASYYCXRCGHW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 577.81 | Molecular Weight (Monoisotopic): 577.3138 | AlogP: 7.95 | #Rotatable Bonds: 9 |
Polar Surface Area: 62.30 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.56 | CX Basic pKa: 6.60 | CX LogP: 8.33 | CX LogD: 8.35 |
Aromatic Rings: 3 | Heavy Atoms: 41 | QED Weighted: 0.28 | Np Likeness Score: -1.31 |
1. (2015) Nitrogen-containing condensed heterocyclic compound, |
Source(1):